Google
Trusted Resources: Community Center
Online groups, photo galleries and blogs
Why Sickle Cell: Ade Adeyokunnu, MBA
The podcast is presented by sickle cell warrior Ade Adeyokunnu. He is also an advocate for sickle cell. He is also an ambassador of Global Blood Therapeutics.
Why I became an advocate for Sickle Cell Disease? The fact that I have it and my sister also has it is the reason for why I became an advocate for the disease. While I was at school, I felt lonely because I didn’t find anyone else going through the same things as I was going through with sickle cell. That was what drove me to start my advocacy for sickle cell and eventually lead me to create this online community for people living with sickle cell back in 2009.
+myBinderRelated Content
-
Beta Thalassemia TraitWhat is beta thalassemia trait? Beta th...
-
For Patients: Sickle Cell TraitSickle cell trait is an inherited blood ...
-
World sickle cell day 2018 documentaryhttps://www.youtube.com/watch?v=x7fLBl3S...
-
Interview with Dr. Keith Wailoo on the journey of medical and social context in treating sickle cell diseaseKeith Wailoo, Professor of history and p...
-
Indiana Sickle Cell Conference 2020 – VirtualThis one-day conference will provide hel...
-
Study challenges view that sickle cell trait increases mortality riskSurprising findings from a study of heal...
-
Sickle Cell + Trait: An Episode of the Sickle Cell PodcastThe Sickle Cell Podcast is an effort by ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
